Doctor Care Anywhere Group PLC (ASX: DOC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Doctor Care Anywhere Group PLC Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Doctor Care Anywhere Group PLC (ASX: DOC)
Latest News
Share Gainers
These 4 small ASX shares are already up more than 19% in 2024!
Share Market News
Reason for hope as 'worst month of the year' starts off badly
Growth Shares
Is it time to buy these 2 beaten-up ASX shares in April 2022?
Growth Shares
Are these 2 top ASX growth shares buys?
Technology Shares
2 top ASX tech shares for February 2022
Technology Shares
2 ASX tech shares that are rapidly growing
Cheap Shares
Down 50%: Broker tips A2 Milk (ASX:A2M) and this ASX share to rebound in 2022
Small Cap Shares
2 small cap ASX shares for 2022 with big potential
Healthcare Shares
Why Doctor Care Anywhere (ASX:DOC) is soaring 12% today
Healthcare Shares
Why is the Doctor Care Anywhere (ASX:DOC) share price getting attention today?
Growth Shares
2 fast growth ASX shares that could be buys in December 2021
Growth Shares
2 ASX shares that may be too good to ignore
DOC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Doctor Care Anywhere Group PLC
Doctor Care Anywhere Group PLC is a telehealth company that provides clinical care through digitally enabled, joined-up, evidence-based pathways on its proprietary platform. It utilizes its relationships with health insurers, healthcare providers, and corporate customers to connect with patients to deliver a range of telehealth services. The Group provides virtual healthcare services, technology platform licencing, and digital design services, within the United Kingdom, Australia, and the Republic of Ireland. The company derives the majority of its revenue from the UK and Ireland.
DOC Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
20 Nov 2024 | $0.07 | $0.00 | 0.00% | 135,403 | $0.07 | $0.07 | $0.07 |
19 Nov 2024 | $0.07 | $0.01 | 15.87% | 58,692 | $0.06 | $0.07 | $0.06 |
18 Nov 2024 | $0.06 | $0.00 | 0.00% | 53,003 | $0.06 | $0.06 | $0.06 |
15 Nov 2024 | $0.06 | $0.00 | 0.00% | 38,533 | $0.07 | $0.07 | $0.06 |
14 Nov 2024 | $0.07 | $0.00 | 0.00% | 353,865 | $0.07 | $0.07 | $0.07 |
13 Nov 2024 | $0.07 | $0.00 | 0.00% | 293,682 | $0.07 | $0.07 | $0.07 |
12 Nov 2024 | $0.07 | $0.00 | 0.00% | 25,051 | $0.07 | $0.07 | $0.07 |
11 Nov 2024 | $0.07 | $0.00 | 0.00% | 104,737 | $0.07 | $0.07 | $0.07 |
08 Nov 2024 | $0.07 | $0.00 | 0.00% | 73,016 | $0.07 | $0.07 | $0.07 |
07 Nov 2024 | $0.07 | $0.00 | 0.00% | 114,182 | $0.07 | $0.07 | $0.07 |
06 Nov 2024 | $0.07 | $0.00 | 0.00% | 92,590 | $0.07 | $0.07 | $0.07 |
05 Nov 2024 | $0.07 | $0.00 | 0.00% | 25,328 | $0.07 | $0.07 | $0.07 |
04 Nov 2024 | $0.07 | $0.00 | 0.00% | 100,001 | $0.07 | $0.07 | $0.07 |
31 Oct 2024 | $0.07 | $0.00 | 0.00% | 88,862 | $0.07 | $0.07 | $0.07 |
30 Oct 2024 | $0.07 | $0.00 | 0.00% | 736,983 | $0.07 | $0.08 | $0.07 |
29 Oct 2024 | $0.07 | $0.00 | 0.00% | 125,153 | $0.08 | $0.08 | $0.07 |
28 Oct 2024 | $0.08 | $-0.01 | -11.90% | 224,506 | $0.08 | $0.08 | $0.08 |
25 Oct 2024 | $0.08 | $0.00 | 0.00% | 83,278 | $0.09 | $0.09 | $0.08 |
24 Oct 2024 | $0.08 | $0.00 | 0.00% | 30,399 | $0.08 | $0.08 | $0.08 |
23 Oct 2024 | $0.08 | $0.01 | 13.16% | 191,570 | $0.08 | $0.08 | $0.08 |
22 Oct 2024 | $0.08 | $0.00 | 0.00% | 31,703 | $0.08 | $0.08 | $0.08 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
05 Mar 2024 | John Stier | Buy | 500,000 | $36,250 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Ms Romana Abdin | Non-Executive Director | Sep 2020 |
Ms Abdin has served as the CEO of Simplyhealth Group for eight years before stepping down in 2021, transforming the business from a sole focus in healthcare funding towards a diversified health and wellbeing business. During her time as CEO, Romana led the restructuring and investment in digital capability to meet the demands of today's customers, employers and healthcare practitioners, developing new propositions, establishing new relationships, developing people capabilities and a leadership team which has shifted the culture from risk averse and analogue to more customer centric, agile and highly engaged. Romana has a industry profile in the UK and has gained commercial, board, governance and regulatory experience in previous roles at Simplyhealth, Lloyds Banking Group and Bradford & Bingley Building Society.
|
Mr David Ravech | Non-Executive Director | Apr 2015 |
Mr Ravech has more than 20 years, David has led and invested in disruptive technology companies. Prior to his involvement with the Group, David was the founder and CEO of Overland Health (now part of Slater and Gordon Solutions), a technology-driven provider of rehabilitation services. He also founded and was later Co-CEO of Global Freight Exchange which provided the world's leading airlines and freight forwarders with the first online price and availability comparison engine and transaction system for airfreight (with the company being sold in 2007 to Descartes (Nasdaq: DSGX), a provider of cloud based logistics and supply chain management solutions).
|
Mr John Robert Stier | Non-Executive ChairmanNon-Executive Director | May 2022 |
Mr Stier has built an executive career as a financial professional, becoming Group CFO of two technology enabled services businesses Northgate Information Solutions Plc and Equiniti Plc. Northgate provides technology and outsourced solutions to the UK Government and global HR market, Equiniti is an international share registrar. John worked with these businesses for over twenty years, helping to build them both into FTSE 250 constituents on the London Stock Exchange.
|
Mr Ben Kent | Chief Executive OfficerExecutive Director | Feb 2023 |
Mr Kent was appointed as interim CEO of the Group in February 2023 following the departure of Mark Taylor due to ill health. Ben was appointed permanent CEO and a Director of the Company on 7 March 2024. Ben has worked in the health sector in the UK and internationally, for nearly 20 years. He has served as Group Director of Finance for Bupa, Chief Financial Officer of Simplyhealth, and was Chief Operating Officer and Chief Financial Officer of Doctor Care Anywhere in 2020 21, working on DCA's listing on the ASX.
|
Dr Aleksandra Spencer | Non-Executive Director | Jul 2023 |
Ms Spencer brings experience in healthcare and life sciences, digital transformation and innovation as well as organisational governance. Aleksandra has a successful record of transforming and growing business through innovation. She gained her experience through working with Fortune 500 companies, including HCA Healthcare, Pfizer and Merck to reshape their strategies; enabling them to transform into patient/consumer experience driven organisations that engage with the Healthcare Providers, Payers, and Patients in an innovative, secure and compliant way. Aleksandra spent several years with IBM in the technology and business consulting sector advising a wide range of clients on how to transform their businesses to adapt to changing market conditions, improve efficiency, increase competitiveness, and ultimately deliver better value to customers and shareholders.
|
Mr Matthew Addison | Non-Executive Director | Oct 2024 |
--
|
Ms Cathy Baxandall | Company Secretary | Feb 2024 |
-
|
Seema Sangar | Chief Financial Officer |
-
|
|
Cathy Baxandall | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Ubs Nominees Pty Ltd | 82,899,716 | 22.61% |
Carani Holdings Limited | 44,264,604 | 12.07% |
Vijay Patel | 26,094,880 | 7.12% |
Bgf Nominees Limited <Bgf Investments Lp A/C> | 18,042,248 | 4.92% |
Buttonwood Nominees Pty Ltd | 16,627,086 | 4.54% |
Gleneagle Securities Nominees Pty Limited | 11,008,636 | 3.00% |
Bhikhu Patel | 8,698,178 | 2.37% |
Hadston 1 Llp\C | 8,587,773 | 2.34% |
Patagorang Pty Ltd <R W Allen A/C> | 8,191,201 | 2.23% |
Lawn Views Pty Ltd <Angela Williams Family A/C> | 6,000,000 | 1.64% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 5,208,177 | 1.42% |
Jasforce Pty Ltd | 3,757,500 | 1.02% |
Bgf Nominees Limited <Bgf Ventures Lp A/C> | 3,742,855 | 1.02% |
Indigenous Capital Limited | 3,116,420 | 0.85% |
Mr Kenneth Joseph Hall <Hall Park A/C> | 2,500,000 | 0.68% |
Barnett Waddingham Trustees (1996) Limited <Anthony Banks Ltd P/P A/C> | 2,406,855 | 0.66% |
Barnett Waddingham Trustees (1996) Limited <Hrmp Directors P/Sch A/C> | 2,406,855 | 0.66% |
Barnett Waddingham Trustees (1996) Limited <Mj Rutherford Ltd D/Pf A/C> | 2,406,855 | 0.66% |
Christopher Robin Moore | 2,369,224 | 0.65% |
The Hospitals Contribution Fund Of Australia Limited | 2,245,236 | 0.61% |